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Abstract
Background: Evidence highlights a high prevalence of common mental health disorders in armed forces veterans
and their families, with depression, anxiety, alcohol misuse and anger being more common than PTSD. This paper
presents a protocol for a systematic review and meta-analysis to identify existing randomised controlled trial (RCT)
research testing the effectiveness of psychological interventions for these difficulties in armed forces veterans and
their family members.
Methods: Electronic databases (CENTRAL, PsycInfo, MEDLINE, CINAHL, The Cochrane Register of Clinical Trials, EMBASE
and ASSIA) will be searched to identify suitable studies for inclusion in the review supplemented by forward and
backward reference checking, grey literature searches and contact with subject authors. Research including armed
forces veterans and their family members will be included in the review with research including serving personnel or
individuals under the age of 18 being excluded. Few RCTs examining the treatment of depression, anxiety, alcohol
misuse or anger exist in armed forces veterans to date. The primary outcome will be symptomatic change following
intervention for these difficulties. The secondary outcomes will include methodological aspects of interest such as
discharge type and recruitment setting if data permits. In the event that the number of studies identified is too low to
undertake a meta-analysis, a narrative review will be conducted. Quality assessment will be undertaken using the
Cochrane Collaboration Tool and Cochran’s Q statistic calculated to test for heterogeneity as suggested by the
Cochrane handbook.
Discussion: The review will examine the findings of existing intervention research for depression, anxiety, alcohol
misuse or anger in armed forces veterans and their families, along with any effect sizes that may exist.
Systematic review registration: PROSPERO CRD42016036676
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Background
The most common mental health disorders in the gen-
eral population are depression, generalised anxiety dis-
order, social anxiety, obsessive compulsive disorder,
panic and post-traumatic stress disorder (PTSD) [1].
Growing evidence exists that some of these disorders are
also highly prevalent in armed forces veterans [2], with
depression, anxiety and alcohol misuse highly prevalent,
and more common than PTSD [3, 4]. Another common
problem for armed forces veterans is anger that can in-
hibit psychosocial functioning and lead to loss of emo-
tional support [5]. It is clear from the research to date
that certain mental health difficulties prevalent in the
general population are also prominent in armed forces
veterans. Further investigation examining interventions
targeting these difficulties is therefore warranted.
Despite the prevalence of these difficulties, many
armed forces veterans do not seek mental health treat-
ment [6]. One of the causes of this may be the anticipa-
tion of stigma, which remains a powerful barrier
preventing members of the UK armed forces accessing
help [7]. Not seeking treatment may exacerbate difficul-
ties for some individuals, as those who are discharged
from service with psychological problems are at high
risk of experiencing ongoing ill health [3]. One group in
which this may be particularly prominent is early service
leavers (those who leave before the minimum term of
their contract) who have poorer mental health and are at
higher risk of developing mental health disorders than
non-early service leavers [8]. No existing review takes
the mental health of early service leavers into account;
therefore, an integration of existing research addressing
early service leavers or ways of altering interventions to
promote participation and reduce barriers to treatment
is required.
The high prevalence of common mental health diffi-
culties is not only limited to armed forces veterans but is
also experienced in their spouses and family members.
This is due to the unique daily stressors they face, such
as relocations and separations that affect all family mem-
bers [9–11]. Given that research indicates a high preva-
lence of mental health difficulties in the family members
of armed forces veterans, this review will focus on re-
search addressing interventions in this population as
well.
Whilst little is known about the mental health treat-
ment of the family members of armed forces veterans,
two systematic reviews exist that examine mental health
treatments for armed forces veterans. The existing sys-
tematic reviews have found cognitive behavioural ther-
apy (CBT) and psychosocial interventions effective for
the treatment of mental health disorders in armed forces
veterans. Kitchiner et al., [12] included 29 randomised
controlled trials (RCTs) examining the efficacy of
psychosocial interventions for anxiety and depressive
disorders in armed forces veterans. They found tele-
phone support effective for the treatment of depression
and at risk drinking in two of the RCTs. Hundt et al.,
[13] included nine studies (five RCTs and four open tri-
als) examining the effectiveness of CBT for depression in
armed forces veterans. The open trials reported larger
effect sizes, which may be due to them having fewer par-
ticipants or arising as a consequence of confounding
methodological factors, with the open trials of lower
methodological quality than the RCTs. Furthermore,
only two of the five RCTs found CBT more effective
than wait-list and psychoeducational control conditions.
Despite these findings, the existing reviews are dated
as they were conducted in 2012 and 2014. In addition to
this, one review was limited to CBT for depression only,
and neither review addressed anger or the mental health
of the families of armed forces veterans. A broader, more
up to date review of the topic area is therefore
warranted.
In developing services and guiding future research, it
is imperative to know the range of evidence-based treat-
ments that are available and have been evaluated in
armed forces veterans and their family members. In
order to broaden the scope of the proposed review, a di-
verse list of search terms has been developed that will
examine the treatment of depression, anxiety, alcohol
misuse or anger in armed forces veterans and their fam-
ilies. This will facilitate a comprehensive review of re-
search in the area of mental health treatments for
depression, anxiety, alcohol misuse or anger in armed
forces veterans, including early service leavers, and their
families.
Methods
Informed by PRISMA-P (Additional file 1) and the
Cochrane handbook for systematic reviews [14, 15], this
protocol was registered a priori with PROSPERO.
Types of study design
The review will include studies with an RCT design,
with both active and inactive control groups. This will
allow causal determinants around the effectiveness of
existing interventions to be reliably explored.
Participants
Participants will include armed forces veterans and fam-
ily members reporting symptoms of depression, anxiety,
alcohol misuse or anger. There is a need to operational-
ise the term ‘veteran’ in this review as the term differs
from country to country. For instance, the Canadian
government considers a veteran to be ‘any former mem-
ber of the Canadian armed forces released with an
honourable discharge and who successfully completed
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basic training’ [16]. This is similar to the US definition
of a ‘person who served in the active military, naval or
air service, and was discharged or released therefrom
under conditions other than dishonourable’ [17]. This
review will use the more inclusive British definition of
‘Those who have served for at least one day in HM
Armed Forces, whether as a regular or reservist’, which
may lead to the inclusion of individuals who would not
have been considered a veteran if an alternative
definition were applied, and includes early service
leavers [18].
Intervention
Studies using psychological or psychosocial interventions
for one of the target disorders/behaviours will be in-
cluded in the review. A psychological intervention is a
treatment that works to modify thoughts, feelings, be-
haviour or emotional state. “A ‘psychosocial intervention’
is a broad term used to describe different ways to sup-
port people to overcome challenges and maintain good
mental health. Psychosocial interventions do not involve
the use of medication” ([19], p2.).
Interventions may be delivered face-to-face as high-
intensity psychological therapy or in a low-intensity for-
mat via the use of CBT self-help interventions with/
without support provided face-to-face, over the tele-
phone or in a written format or a combination of these
support modalities. In order to reduce bias associated
with short-term posttreatment effects, effect size will be
calculated from data obtained both at immediate post-
treatment up to 6 months follow-up.
Studies that report pharmaceutical interventions plus
therapy intervention groups will be included in the re-
view; however, those focusing solely on psychopharma-
cological interventions will be excluded.
Comparators
Potential comparators could include treatment as usual,
alternative treatment, watchful waiting, attention control
or information provision groups.
Outcomes
The primary outcome in this review will be symptomatic
change in depression, anxiety, anger or alcohol misuse
in armed forces veterans or their family members on
standardised measures between intervention and control
groups post intervention and up to 6 months post inter-
vention. Symptomatic change may be from formal diag-
nosis or observer-rated or self-report measures such as
PHQ-9, GAD-7, AUDIT and NAS-PI [20–23]. Outcomes
post intervention up to and including 6 months post
intervention will be extracted to enable a potential mod-
erator analysis on length of follow-up. Secondary out-
comes will include methodological aspects of interest
such as comparator group or recruitment settings or
follow-up outcomes which will allow the impact these
factors may have in relation to primary outcomes to be
explored. Effect sizes will be calculated using the
Campbell Collaboration effect size calculator [24], exam-
ining the differences that comparator groups or recruit-
ment settings may have on outcomes. Studies will be
categorised by target disorder, with studies with multiple
target disorders discussed in each category. Studies with
multiple outcome measures per target disorder will be
detailed in the narrative analysis. Meta-analyses will be
conducted for each target disorder and comparator where
data allows. The measure used in the meta-analysis was
based on the following hierarchy: depression (PHQ-9,
Hamilton rating scale for depression—HRSD, Beck de-
pression inventory—BDI [20, 25, 26]), anxiety (GAD-7,
State-trait anxiety inventory—STAI, Beck Anxiety
Inventory and the Hospital Anxiety and Depression Scale
[21, 27–29]), anger (NAS-PI, DAR, State-trait anger ex-
pression inventory—STAXI [23, 30, 31]), alcohol misuse
(Audit, Timeline follow-back—TLFB [22, 32]) where mul-
tiple outcome measures have been used in studies. No
general categories will be employed with studies being re-
quired to directly measure one of the four target disorders
in order to warrant inclusion in the review. In order to
control for upward bias, only target outcomes shall be
analysed with secondary disorders identified through
questionnaire battery not included.
Methods for identification of studies
Electronic searches of CENTRAL, PsycInfo, MEDLINE,
CINAHL, The Cochrane Register of Clinical Trials,
EMBASE and ASSIA will be undertaken using free
text, MESH headings and Boolean operators, with the
search adjusted to fit each database. A proposed
search strategy for the MEDLINE database is attached
(Additional file 2).
Forward and backward citations will be explored by
examining the reference lists of identified studies. A grey
literature search will also be undertaken examining con-
ference proceedings, grey literature databases and rele-
vant websites. Subject authors will be contacted to
identify missing data and any additional studies that
meet the inclusion criteria. There will be no country ex-
clusions for studies; however, only studies available in
English will be included in the review.
The search process will begin with title and abstract
examination by LO, with full papers then obtained and
compared against the inclusion/exclusion criteria. A sub-
set of the papers (10%) will also be reviewed by an inde-
pendent reviewer not connected to the study in order to
check reliability using a Kappa statistic [33]. Any dis-
crepancies about study inclusion will be resolved
through discussion in consensus meetings.
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A PRISMA flow chart will be produced. The initial
database searches will take place between June and July
2016. The next steps of the research process will depend
on the number of studies identified. Any study published
in English up to the date that the searches commence
will be included in the review.
Data extraction and analysis
A data extraction form will be produced and trialled.
Missing data will be requested from authors. If it is not
possible to obtain missing data, sensitivity analysis will
be conducted to assess the impact of removing this
study from the data analysis on any statistical synthesis
of data. Data extraction will be undertaken by LO again
checked by an independent reviewer to test for reliabil-
ity. Any discrepancies will again be resolved through dis-
cussion at consensus meetings. Data to be extracted will
cover the following areas: participant characteristics
(number, age, gender, rank, regular or reservist etc.), ser-
vice branch (Army, Navy, Airforce), intervention used
(face-to-face high intensity therapy, self-help, guided
help etc.), comparator group(s) (treatment as usual, al-
ternative treatment, watchful waiting), outcome mea-
sure(s) used (PHQ-9, GAD-7, HADS, AUDIT, BDI,
NAS-PI), study outcome (symptomatic change and any
associated effect size) with discrepancies resolved
through discussion. Follow-up data will be extracted
where applicable. Standard mean difference between
intervention group(s) and control post intervention,
along with the respective 95% confidence intervals, will
be calculated using the Campbell Collaboration effect
size calculator using study outcome means, standard de-
viations and number of participants [24]. This will be
done using between groups post intervention and
follow-up (up to and including 6 months post interven-
tion) means, standard deviations and number of partici-
pants, with missing data again requested from study
authors. As the review only focuses on symptomatic
change, dichotomous data will not be applicable.
Risk of bias
Quality assessment will be conducted using the
Cochrane Collaboration Tool [34]. The tool will allow
the quality of identified studies to be discussed in a
manner consistent with the Centre for Reviews and
Dissemination guidelines [35]. Studies identified as poor
quality will be dropped from the analysis in order to im-
prove the reliability of findings.
Extracted data will be presented in a tabulated format.
A risk of bias table will be compiled using RevMan [36].
Data synthesis
Where a sufficient number of papers meeting inclusion
criteria are identified, meta-analysis will be undertaken.
Although meta-analysis can be conducted with as little
as two studies, if a large amount of heterogeneity exists,
concerns regarding the reliability of any statistical syn-
thesis can arise. In addition to this, because a random ef-
fects model will be used, a small number of studies may
lead to an error in the between studies variance estima-
tion. The number of studies identified and the level of
heterogeneity will therefore be taken into account when
considering the suitability of the data for a meta-
analysis. If a meta-analysis is deemed appropriate, effect
sizes (standardised mean difference, Cohen’s d) and 95%
confidence intervals will be calculated again using the
Campbell Collaboration effect size calculator [24] with
forest plots produced to visually represent findings.
Effect size will be interpreted using Cohen’s classifica-
tion (small, 0.20 to 0.49; medium, 0.5 to 0.79; large
>0.80) [37].
In the event that only a small number of studies are
identified with a large amount of heterogeneity present,
a full narrative review will be undertaken using the
‘Narrative Synthesis in Systematic Reviews’ tool [38]
which will allow for a textual approach to be adopted
and applied, explaining the findings of the study data.
It is expected that a number of different interven-
tions will be examined across studies. Therefore, a
random effects model will be adopted, as advised by
Borenstein [39]. Cochran’s Q statistics will be calcu-
lated to test for heterogeneity, with I2 statistics calcu-
lated to quantify the degree of heterogeneity found. If
at least 10 studies are identified (as per Cochrane
handbook for systematic reviews of interventions ad-
vice [15]), funnel plots will be produced using
RevMan [36] to check for publication bias with
Eggers’ test of intercept used to determine if funnel
plot asymmetry exists [40].
If heterogeneity exists, subgroup analysis will be con-
ducted in order to determine whether this is due to
methodological or participant factors. Moderators may
include clinical presentation, branch of service, high/
medium quality study, country of origin and early ser-
vice leaver vs non-early service leaver, or methodological
moderators such as recruitment source.
Discussion
The effectiveness of existing interventions for depres-
sion, anxiety, alcohol misuse and anger in armed forces
veterans and their families will be explored through the
planned systematic review.
The two existing reviews [12, 13] in the area of armed
forces veteran mental health have employed narrow
searches. Therefore, the effectiveness of interventions
addressing anger and alcohol misuse remains unknown.
The proposed review will employ a robust method fol-
lowing PRISMA, Cochrane and CRD guidelines and a
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broad range of search terms used to establish a compre-
hensive picture of the research in the area to date.
Most research addressing the mental health of armed
forces veterans has been conducted in the USA. This re-
view will attempt to adopt a more inclusive approach by
using the British definition of the term armed forces vet-
eran, which may lead to the inclusion of studies that
may have been excluded when a narrower definition of
veteran, such as that used in the USA, is applied.
Given the prevalence and significant impact of poor
mental health in armed forces veterans, results of this
review may be important in guiding future research,
service development, clinical practice and health care
policy such as the armed forces covenant that focuses
on the mental health of armed forces veterans and
their families [18].
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